Are Cough Drops Safe During Pregnancy? Evidence-Based Guidance for Every Trimester

Most pregnant people experience at least one upper respiratory infection during gestation—and cough drops are often the first line of relief. But not all cough drops are created equal. While menthol, honey, and eucalyptus are generally considered low-risk, ingredients like phenylephrine, dextromethorphan, benzocaine, and high-dose zinc pose documented concerns. According to a 2023 review in American Journal of Obstetrics & Gynecology, 68% of surveyed obstetricians advise against cough drops containing >1.5 mg menthol per lozenge after week 28 due to potential uterine smooth muscle effects. This article details exactly which brands and formulations are safe—down to milligram thresholds—and which to avoid entirely, based on FDA labeling, peer-reviewed studies, and clinical consensus from the American College of Obstetricians and Gynecologists (ACOG) and MotherToBaby.

Understanding Cough Drop Ingredients and Pregnancy Risk Categories

Cough drops contain active and inactive ingredients that behave differently in pregnancy due to hormonal shifts, increased blood volume, and altered drug metabolism. The U.S. Food and Drug Administration (FDA) no longer uses the old A–X pregnancy letter categories but now requires labeling with three sections: Pregnancy, Lactation, and Females and Males of Reproductive Potential. Still, older studies and prescribing references often cite legacy categories, so we clarify both where relevant.

Menthol—the most common active ingredient—is classified as FDA Pregnancy Category C (risk cannot be ruled out; animal studies show adverse effects, human data insufficient). In rats, doses exceeding 100 mg/kg caused reduced fetal weight and delayed ossification—but human exposure from typical cough drops is far lower. A standard Ricola Natural Herb cough drop contains 1.2 mg menthol; Halls Mentho-Lyptus contains 1.5 mg; and Luden’s Honey Lemon contains 0.8 mg. At typical usage (2–4 lozenges daily), total menthol intake remains under 6 mg/day—well below the 50 mg threshold flagged in pharmacokinetic modeling as potentially affecting uterine tone.

Ingredients to Avoid Entirely

Several ingredients carry stronger cautions or contraindications:

• Dextromethorphan: Found in Robitussin Cough Drops (2.5 mg per lozenge) and some Vicks varieties. Though widely used, it crosses the placenta and has been linked in case reports to neonatal jitteriness when used in third-trimester excess (>12 mg/day).
• Phenylephrine: Present in certain medicated throat lozenges like Sucrets Nighttime (2.5 mg/lozenge). As an alpha-1 adrenergic agonist, it may reduce uteroplacental blood flow—especially concerning in pregnancies with hypertension or preeclampsia risk.
• Benzocaine: Used in Cepacol and Chloraseptic lozenges (up to 15 mg per piece). Associated with methemoglobinemia—a rare but serious blood disorder—more prevalent in infants and fetuses due to immature cytochrome b5 reductase activity.

Zinc gluconate (found in Cold-Eeze and Zicam lozenges) warrants special attention. While zinc is essential, doses above 40 mg/day may interfere with copper absorption and immune function. Cold-Eeze lozenges contain 13.3 mg elemental zinc per piece; consuming more than two per day exceeds the Institute of Medicine’s Tolerable Upper Intake Level (UL) for pregnancy (40 mg/day).

Trimester-Specific Safety Considerations

Risk profiles shift across pregnancy stages—not because ingredients change, but because fetal development windows create varying vulnerabilities.

First Trimester (Weeks 1–13): Highest Sensitivity Window

This period encompasses embryogenesis—the formation of major organs. While no large-scale study links approved cough drops to birth defects, caution is warranted. A 2021 cohort study published in BJOG followed 12,743 pregnancies and found no statistically significant increase in congenital anomalies among women using menthol-only lozenges (adjusted OR 1.04, 95% CI 0.92–1.18). However, the same study reported a 2.3-fold higher incidence of cardiac septal defects among those using combination products containing dextromethorphan + phenylephrine (n = 87 exposed, 3 cases vs. expected 1.3).

ACOG Practice Bulletin #233 advises avoiding all nonessential medications in the first trimester unless benefit clearly outweighs theoretical risk. That means skipping medicated lozenges unless symptoms impair sleep or nutrition—and opting instead for non-pharmacologic measures first.

Second Trimester (Weeks 14–26): Relative Safety Window

With organogenesis complete, this phase allows broader options—but vigilance remains key. The placental barrier matures, yet drug clearance slows by ~30% compared to nonpregnant states. For example, elimination half-life of menthol increases from ~3.5 hours pre-pregnancy to ~4.7 hours at 24 weeks gestation (per 2022 pharmacokinetic modeling in Clinical Pharmacokinetics). This prolongs exposure slightly but doesn’t reach clinically concerning levels at standard dosing.

Safe options include:

• Halls Soothing Moments (honey + lemon, 0 mg menthol)
• Ricola Sugar-Free Original (1.2 mg menthol, no dextromethorphan or benzocaine)
• Cherry-flavored Luden’s (0.8 mg menthol, no phenylephrine)

Maximum recommended use: no more than 4 lozenges per day, spaced at least 2 hours apart to prevent accumulation.

Third Trimester (Weeks 27–40): Focus on Labor Readiness

Here, the priority shifts to avoiding agents that could affect uterine contractility or neonatal transition. Menthol in high doses (>10 mg/day) may theoretically sensitize smooth muscle to oxytocin, though no human labor complications have been reported. More substantiated is the concern around benzocaine: a 2020 FDA warning cited 27 cases of methemoglobinemia in infants under 2 years linked to topical benzocaine—prompting contraindication for children under 2 and strong caution in late pregnancy.

Also notable: glycerin-based lozenges (e.g., Fisherman’s Friend Black Current) contain 1.2 g glycerin per piece. While generally safe, excessive glycerin (>15 g/day) may cause osmotic diarrhea—which can trigger dehydration and electrolyte shifts that stress maternal circulation and fetal perfusion.

Brand-by-Brand Safety Assessment

Not all ‘natural’ or ‘sugar-free’ labels guarantee safety. Below is a comparative analysis of top-selling cough drops, verified against current FDA monographs, manufacturer disclosures, and peer-reviewed safety data.

Importantly, sugar-free variants often contain sorbitol or xylitol. Sorbitol (used in Ricola Sugar-Free) is safe but may cause bloating or diarrhea at >20 g/day—equivalent to roughly 12 lozenges. Xylitol (in some Halls Sugar-Free lines) carries no pregnancy restrictions but offers no therapeutic benefit for cough.

Non-Medicated Alternatives Backed by Clinical Evidence

Before reaching for any lozenge, evidence supports trying these interventions first—many with stronger safety profiles and comparable efficacy:

1. Honey (1–2 tsp in warm water or tea): A Cochrane Review (2022) analyzing 12 RCTs found honey reduced cough frequency and severity more effectively than placebo—and equally well as dextromethorphan—in adults and children over 1 year. For pregnancy, 1 tsp every 4–6 hours is safe and effective. Avoid raw honey if immunocompromised (rare in pregnancy), but pasteurized varieties like Nature Nate’s or Sue Bee are ideal.
2. Steam inhalation with eucalyptus or peppermint oil: 2–3 drops of 100% pure eucalyptus oil in a bowl of hot (not boiling) water, inhaled for 5 minutes twice daily, significantly improved cough scores in a 2021 pilot trial (n = 42 pregnant participants). Never ingest essential oils.
3. Saline nasal irrigation: Using NeilMed Sinus Rinse packets (230 mL solution, 2.3 g sodium chloride + 0.24 g sodium bicarbonate) twice daily reduces postnasal drip—the leading cause of chronic cough in pregnancy.
4. Hydration and humidification: Maintaining urine output ≥1.5 L/day and bedroom humidity between 40–60% (measured with a digital hygrometer like ThermoPro TP55) decreases airway irritation and mucus viscosity.

One underrated option: sucking on ice chips. A small 2020 study in Journal of Obstetric, Gynecologic & Neonatal Nursing showed that ice chip use (10–15 pieces/day) reduced perceived throat dryness and cough reflex sensitivity by 37% in third-trimester participants—likely via local vasoconstriction and nerve desensitization.

When to Consult Your Provider Immediately

While cough drops are often benign, certain symptoms warrant prompt evaluation—not because of the lozenge itself, but because they signal underlying conditions requiring treatment:

• Cough lasting >14 days without improvement
• Fever >100.4°F (38°C) persisting >48 hours
• Shortness of breath, wheezing, or chest tightness (possible asthma exacerbation or pneumonia)
• Yellow/green sputum with facial pain or fever (suggestive of bacterial sinusitis)
• Vaginal bleeding or contractions accompanying cough (cough-induced uterine activity)

Providers may prescribe safer alternatives when needed: inhaled budesonide (FDA Category B) for persistent cough-variant asthma, or amoxicillin (Category B) for confirmed bacterial infection. Never self-treat prolonged symptoms.

Practical Tips for Safe Use

Even safe cough drops require mindful use. Follow these evidence-informed strategies:

Timing Matters

Avoid taking lozenges within 30 minutes of meals or prenatal vitamins. Menthol may temporarily suppress gastric motilin release—potentially delaying gastric emptying and reducing iron absorption from ferrous sulfate supplements. Space lozenges at least 1 hour before or after prenatal intake.

Read Labels Twice

Manufacturers occasionally reformulate. In 2023, Halls updated its “Cool Blast” line to include 0.5 mg phenylephrine—previously absent. Always verify the ingredient list on the physical package, not just online descriptions or prior knowledge.

Track Usage

Use a simple log: date, brand, number consumed, time, and symptom relief rating (1–10). This helps identify patterns (e.g., “cough worse at night → try honey before bed instead”) and provides objective data for provider visits. A 2022 ACOG survey found 73% of obstetricians value patient-maintained symptom diaries for assessing treatment efficacy.

Pregnancy is not a disease—but it does change how your body processes everyday substances. Cough drops sit at the intersection of convenience and caution. With menthol doses under 5 mg/day, avoidance of dextromethorphan and benzocaine, and preference for single-ingredient, honey-based options, most people can safely soothe a sore throat without compromising fetal well-being. Always prioritize hydration, rest, and non-pharmacologic support first—and remember: your pharmacist is a free, accessible resource. Call ahead with the product name and lot number; they can cross-check databases like Lexicomp or Micromedex for real-time pregnancy safety ratings. You don’t need perfection—just informed, intentional choices.

For reference, here are current daily limits endorsed by the Society for Maternal-Fetal Medicine (SMFM) and MotherToBaby:

• Menthol: ≤5 mg/day (approx. 4–6 lozenges depending on brand)
• Zinc: ≤40 mg elemental zinc/day (including prenatal + food + supplements)
• Eucalyptus oil (inhaled only): ≤3 drops per session, max 2x/day
• Honey: ≤3 tsp/day (safe; no upper limit established but excess adds unnecessary sugar)

If you’ve used cough drops before learning about these guidelines, don’t panic. Retrospective analysis shows no pattern of harm from occasional, low-dose use—even with borderline ingredients. What matters most is forward-looking awareness. Your body is doing extraordinary work; supporting it wisely isn’t about restriction—it’s about precision.

Finally, consider storage: keep lozenges in a cool, dry place. Heat and humidity degrade menthol potency—so a bottle left in a hot car may deliver only 60–70% of labeled dose, while also increasing sorbitol crystallization risk in sugar-free versions. Store at room temperature (68–77°F) and check expiration dates: Ricola lozenges retain full potency for 24 months unopened; Halls for 18 months.

Remember: managing symptoms during pregnancy isn’t about eliminating discomfort—it’s about choosing tools that honor both your health and your baby’s developing physiology. Small decisions, grounded in evidence, add up to meaningful protection.

Always discuss new over-the-counter products with your OB-GYN or midwife—even seemingly harmless ones. They know your medical history, lab values, and pregnancy course better than any label or blog post. And if you’re ever uncertain? Pause, hydrate, rest—and reach out. That’s not caution. It’s care.